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 Caveolins are such integral membrane proteins that are
principal components of the special, ω-shaped plasma mem-
brane invaginations called caveolae. Multiple forms of caveolin
have been identified: caveolin-1-α, caveolin-1-β, caveolin-2,
and caveolin-3. They differ in their specific properties and
tissue distribution. Caveolin-1 and caveolin-2 may originate
from a common ancestor. They are most abundantly expressed
in adipocytes, endothelial cells, fibroblasts and smooth muscle
cells [1-3]. The expression of caveolin-3 is thought to be muscle
specific [4-6], although it has been shown that they are present
in astroglial cells [7] and neurons of vegetative ganglions [8].
Scherer et al. [3] identified two caveolin isoforms in
Caenorhabditis elegans. Their findings indicated that caveolins
are structurally and fuctionally conserved across species from
worms to human. These data suggest that caveolins might have
an important evolutionary role. The short cytoplasmic domain
of the N-terminal region of caveolin isoforms forms multiva-
lent homo- and hetero-oligomers of caveolins [1]. In contrast
to caveolin-1, caveolin-2 was not found to form homo-oligo-
mers. This latter isoform exists mainly as a monomer [2], or it
forms stable hetero-oligomeric complexes with caveolin-1 [3].
Thus, caveolin-2 may function as an accessory protein in con-
junction with caveolin-1 [1]. It has been proposed that the
caveolin family members function as scaffolding proteins to
organize and concentrate specific lipids (cholesterol and
glycosphingolipids), lipid-modified signaling molecules and
G proteins within caveolae. Binding may suppress or inhibit
enzyme activity through the caveolin scaffolding domain,
which is a common caveolin domain.
There are only a few published reports about the pres-
ence and distribution of caveolin in the retina. Caveolin-1 was
found to be present in the outer plexiform layer (OPL) of mouse
retina in the synaptic ribbon in photoreceptor terminals [9]. In
another study caveolin-1 was detected in various layers of the
rat retina, from the inner plexiform layer (IPL) to the outer
limiting membrane (OLM), suggesting that caveolin-1 is ex-
pressed in Müller cells. Using specific markers, Scherer et al.
confirmed Müller cells do contain caveolin [10]. Caveolin-1
was also discovered to be present in pigment epithelial cells.
Laser scanning confocal microscopical analysis of intact reti-
nal pigment epithelium (RPE) localized caveolin-1 to the api-
cal and basal surfaces [11]. Recently Kim et al. [12] reported,
caveolin-1 was present in the majority of retinal layers in the
rat retina. Caveolin-2 immunostaining was much weaker, how-
ever it was intensely detected around the blood vessels.
Caveolin-2 stained in the processes of glial cells and Muller
cells, but immunoreactivity was very limited in retinal neu-
ronal cells including the ganglion cells, amacrine cells, bipo-
lar cells, horizontal cells, and photoreceptor cells. Only cen-
tral regions of the retina were involved in the study. No ex-
aminations were made about caveolin-3.
There are no data available about the distribution of
caveolins in the human retina. Therefore, the aim of our study
was to investigate the localization of caveolin isoforms in the
human retina. Since immunocytochemical analysis of the retina
requires special preparation, including immediate and precise
fixation, we used only enucleated human eyes for our experi-
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881ments. We chose retinas affected by melanoma malignum
choroideae, a common reason for enucleation. The quantity
and the distribution of the caveolin isoforms were obviously
different in the human retina compared to other species. The
caveolins were present in many regions and layers in the hu-
man retina. They were present in both neuronal and glial cell
types, which suggests, that caveolins must play a role in the
functions of these cells.
METHODS
Material:  Three patients were involved in the study: two males
(ages: 50, 57) and one female (age: 50). These patients were
operated after the diagnosis of posterior uveal melanoma
(melanoma malignum choroideae) in 2005 at the Department
of Ophthalmology, University of Debrecen. The enucleation
was made without prior treatment (brachytherapy was disquali-
fied). Thus the retinas were not damaged due to any other
treatment and stayed as intact as possible.
After the enucleation the eyes were included into histo-
pathological study. The histological types according to
Callendar’s classification were: spindle A (male patient, age:
50), dominantly spindle B (female patient, age: 50), and domi-
nantly epitheloid tumor (male patient, age: 57), respectively.
All experiments involving human subjects were carried out
according to the Helsinki Declaration and with the approval
of the Human Studies Ethical Committee, University of
Debrecen.
Preparation of the retina:  Immediately after enucleation
a dorsal stitch was made for orientation. A non-infiltrated part
of the eye was removed for further investigation, the rest was
sent to histopathology. The former section was subsequently
placed in the fixative (4% paraformaldehyde, in 0.1 M phos-
phate buffer, pH 7.4), and incubated for 24 h at 4 °C. Thereaf-
ter the solution was replaced with 0.1 M phosphate buffered
saline (PBS, pH 7.4), and rinsed for at least 24 h before fur-
ther processing. The retina was carefully detached from the
posterior eyecup. Extreme care was taken to obtain samples
from the peripheral part of the retina, and from behind the ora
serrata. These ciliary and iridic regions can not be separated
from the ciliary body and the iris, so they were handled to-
gether. For frozen sections the retinas were incubated over-
night in 30% sucrose (diluted in 0.1 M phosphate buffer),
embedded in cryomatrix (ThermoShandon Pittsburgh, PA), and
frozen in liquid nitrogen. Next, 10 µm thick radial sections
were prepared on a ThermoShandon cryotome. For radial
semithin sectioning three samples were taken from the human
retina following a radial plane including the macular region
(M), periphery (P), ciliary body (CB).
Immunocytochemistry:  Sections of 10 µm thickness were
cut on a cryostat and dried onto poly-L-lysine coated glass
microscope slides at 37 °C. Sections were then soaked in PBS
for 20 min. A blocking solution of, 1% bovine serum albumin
(BSA) with 0.1% Triton X-100 was applied for 2 h. The pri-
mary antibody was applied at 4 °C overnight. Primary anti-
bodies anti-caveolin-1 (polyclonal rabbit IgG, Transduction
Laboratories, BD Biosciences, San Jose, CA), 1:100, anti-
caveolin-2 (monoclonal mouse IgG, Transduction Laborato-
ries), 1:200, and anti-caveolin-3 (monoclonal mouse IgG,
Transduction Laboratories) 1:100, were diluted in 1% BSA at
4 °C overnight. Caveolin-1 and -3 anti-rabbit and anti-mouse
Alexa 488 (Molecular Probes, Invitrogen, Carlsbad, CA) were
used as secondary antibodies. Since caveolin-2 gave a weakly
detectable signal with the previous method, we used
biotinylated anti-mouse IgG, then Streptavidin Alexa 488
(Molecular Probes), 1:100, to intensify the signal. Even with
this extra method, caveolin-2 still gave a weak signal. For vi-
sualization of the cytoskeleton, we used Alexa fluor 594-la-
beled phalloidin (Molecular Probes) to stain F-actin (1:100).
Vectashield HardSet Mounting Medium (Vector Laboratories,
Burlingame, CA) with DAPI (4',6-diamidino-2-phenylindole)
was used to cover the slides. When DAPI binds to DNA, its
fluorescence is strongly enhanced, with excitation wavelength
350 nm (nuclei appear blue). Control reactions were made
using rabbit and mouse normal serum, non-specific primary
antibodies, and by omitting the primary antibodies to preclude
non-specific binding. The retinas were inspected on a Zeiss
Axiophot microscope Thornwood, NY, using the appropriate
filter set for the fluorescent antibodies. Micrographs were ob-
tained using an Olympus DP50 camera. Fluorescent double-
or triple-labeled specimens were also inspected on a Radi-
ance 2100 Multi Photon Imaging System coupled to a Nikon
Eclipse E800 microscope using LaserSharp 2000. Both Adobe
Photoshop 7.0 and Confocal Assistant were used for primary
image processing.
RESULTS
Caveolin-1:  The bound antibody was present in all layers of
the retina. The weakest staining could be found in the pig-
ment epithelium (low). The autofluorescence of the pigment
granules made assessment of the immunostaining density more
difficult. However the immunoreactive deposits were signifi-
cantly smaller than the pigment granules, so the formers could
be clearly identified. In other layers the density was estimated
to vary from low to very high. The distribution of
immunolabeling exhibited a characteristic center-to-periph-
eral gradient, increasing from very low, to low, moderate, and
high density (M, Figure 1A,D,F), reaching the maximum level
(very high; P Figure 1B,E,G), then decreasing towards the
extreme peripheral part of the retina (very low, low; CB Fig-
ure 1C). (Figure 1, Table 1).
Caveolin-2:  Caveolin-2 immunoreactivities (IRs) were
found to be present from the outer nuclear layer (ONL) to the
inner limiting membrane (ILM), showing very low, low and
moderate densities (M, Figure 2A,D,F). However no IRs were
detected at the peripheral part (P, Figure 2B,E) in the IPL, the
layer of the optic nerve fibers and the ILM. In the epithelium
of the ciliary body (CB, Figure 2C) no IRs could be seen.
(Figure 2, Table 2).
Caveolin-3:  In the macular region, caveolin-3 immunore-
activity was present from the INL to the ILM with very low,
low and moderate densities (M, Figure 3A,D,F). At the pe-
riphery (P, Figure 3B,E,G) IRs also were in the layer of the
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882outer segments (low). Caveolin-3 signals of low and moder-
ate densities were present in both layers of the ciliary body
(CB, Figure 3C, Table 3).
Table 1, Table 2, and Table 3 present a summary of
immunostaining densities in various tissue samples. Differ-
ences among the various sites were obvious, and only
semiquantitative scoring was used. In contrast to monoclonal
antibodies polyclonal sera may exhibit a reactivity against
multiple epitopes. Accordingly, to avoid any uncertainty,
caveolin isoform immunocytochemistry was performed with
utmost care using a wide range of controls. For the same rea-
son, the distribution of caveolin-1 detected by a polyclonal
antibody was studied separately from that of the other two
isoforms.
DISCUSSION
Caveolin-1:  Caveolin-1 expression has only been studied in
rodent retinas. It was found to be present in the outer plexi-
form layer in mouse retina at the synaptic ribbon in photore-
ceptor terminals [9], and also detected in Müller cells and pig-
ment epithelial cells of the rat retina [10,11]. Song et al. re-
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Figure 1. Immunocytochemical analy-
sis of caveolin-1 in the human retina.
Samples were taken from different sites
the retina following a radial plane from
the central to the peripheral retina. A,
D, F: Macular region, M. B, E, G: Pe-
riphery, P. C: ciliary body, CB. Alexa
Fluor 488 was used to detect caveolin-
1 (green). The cytoskeleton and the nu-
clei were treated with Alexa fluor 594
labeled phalloidin (red) and DAPI
(blue), respectively. Merged images are
presented. Caveolin-1 was present in all
layers of the retina. Weakest signals
could be seen in the pigment epithelium
(low A). The different regions showed
a center-to-peripheral gradient; increas-
ing from very low, low, moderate and
high density (M, A, D, F), reaching the
maximum level (very high; P, B, E, G),
then decreasing towards the extreme
periphery of the retina (very low, low; CB, C). Pigment granules showed autofluorescence, but they could be distinguished from caveolin
signals. Scale bar represents 10 µm. The following abbreviations were used: pigment epithelium (PE), outer segments (OS), outer limiting
membrane (OLM), outer nuclear layer (ONL), outer plexiform layer (OPL), inner nuclear layer (IPL), inner plexiform layer (INL), ganglion
cells (GC), optic nerve fibers (ONF), inner limiting membrane (ILM).
TABLE 1. SUMMARY OF LABELING DENSITY OF CAVEOLIN-1 AT
DIFFERENT SITES IN HUMAN RETINA
Region   M      P       CB
------   ----   -----   --
PE       +      +++++   +
OS       ++     +++++   ++
OLM      ++     +++++
ONL      +++    +++++
OPL      ++++   +++++
INL      +++    +++++
IPL      +++    +++++
GC       ++++   +++++
ONF      ++++   +++++
ILM      ++++   +++++
Caveolin-1 was present in all layers of the retina. Weakest signals
were detected in the pigment epithelium (low). A center-to-periph-
eral gradient was observed: very low, low, moderate and high den-
sity at the central part (M), maximum level (very high) at the periph-
ery (P), very low and low at ciliary body (CB). - indicates none; +
indicates very low; ++ indicates low; +++ indicates moderate; ++++
indicates high; +++++ indicates very high.
883ported, caveolin-1 was present in the majority of retinal lay-
ers in the rat retina [12]. Caveolin-1 is known to be expressed
abundantly in adipocytes, endothelial cells, fibroblasts, and
smooth muscle cells. The observations of Song et al. and oth-
ers confirm, that caveolin-1 is also expressed in some neu-
ronal and glial cell types. No data are available about the dis-
tribution of caveolin-1 in the human retina yet, but studies on
mammalian retinas suggest, that the densities of different
caveolin types seem to be much lower compared to our sec-
tions. Caveolin-1 was only observed in a few cell types [9-11]
and layers [12], including the ganglion cell layer, IPL, OPL,
and in the vascular endothelial cells of the rat retina. Our ob-
servations show, caveolin-1 is evenly distributed among the
different layers of the human retina, including the epithelium
of the ciliary body. Although each cell type was not identified
with specific markers, it was still obvious, that caveolin-1 is
expressed in many cell types, including pigment cells, outer
segments of photoreceptors, ganglion cells, and probably also
in all the other cell types as well. Interestingly, the density of
caveolin-1 exhibited a characteristic center-to-peripheral varia-
tion; after an increase toward the mid-periphery it reached a
maximum level and then started to decrease toward the ora
serrata.
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Figure 2. Immunocytochemical analysis of caveolin-2 in the human retina.
Samples were taken as described in Figure 1. Alexa Fluor 488 was used to
detect caveolin-2 (green). The cytoskeleton and the nuclei were treated
with Alexa fluor 594 labeled phalloidin (red) and DAPI (blue), respec-
tively. Merged images are shown. Caveolin-2 was found in the outer nuclear
layer (ONL) and the inner limiting membrane (ILM), including the inter-
vening layers. A, D, and F reveal: very low, low, and moderate densities
(M). B, E: At the peripheral part (P) immunoreactivities (IRs) were ob-
served only in the outer nuclear layer (ONL), outer plexiform layer (OPL),
inner nuclear layer (INL), and ganglion cell (GC; very low, low). C: No
signals were observed at the epithelium of the ciliary body (CB). Note, that pigment granules show autofluorescence. Scale bar represents 10
µm. The following abbreviations used in this figure: pigment epithelium (PE), outer segments (OS), outer limiting membrane (OLM), inner
nuclear layer (IPL), optic nerve fibers (ONF).
TABLE 2. SUMMARY OF LABELING DENSITY OF CAVEOLIN-2 AT
DIFFERENT REGIONS IN HUMAN RETINA
Region   M     P    CB
------   ---   --   --
PE       -     -    -
OS       -     -    -
OLM      -     -
ONL      ++    +
OPL      ++    ++
INL      +     ++
IPL      +     -
GC       ++    ++
ONF      +++   -
ILM      +++   -
Caveolin-2 was found in the outer nuclear layer (ONL) and the inner
limiting membrane (ILM), including the intervening layers, show-
ing very low, low and moderate densities (M). Very low and low
density was seen at the periphery (P), but no signals were observed
at the most peripheral part (CB). - indicates none; + indicates very
low; ++ indicates low; +++ indicates moderate; ++++ indicates high;
+++++ indicates very high. Following abbreviations are used: pig-
ment epithelium (PE), outer segments (OS), outer limiting membrane
(OLM), outer plexiform layer (OPL), inner nuclear layer (IPL), in-
ner plexiform layer (INL), ganglion cells (GC), optic nerve fibers
(ONF).
884Caveolin-2:  In previous studies, caveolin-2 was described
to be present only around blood vessels of the rat retina [10,12].
This correlates with the fact, that caveolin-2 is expressed in
adipocytes, endothelial cells, fibroblasts, and smooth muscle
cells. Our observations confirmed the following: caveolin-2
is clearly localized around the human blood vessels. Caveolin-
2 is also expressed in many layers in the human retina from
the ONL to the ILM, indicating its presence in neuronal cell
types. It is worth mentioning, that the most peripheral part of
the human retina also expressed caveolin-2. The latter part,
the epithelium of the ciliary body, was not examined previ-
ously in rodents.
Caveolin-3:  Until the present study, no studies examined
the presence of caveolin-3 in the human retina. Caveolin-3
remains to be studied in rodent retinas. Traditionally, caveolin-
3 has been thought to be muscle specific, however it has been
detected in astroglial cells and vegetative ganglions [8]. It is
also known that the expression of caveolin-3 is intense in the
central nervous system in early embryonic stages in the chicken
[13].
The distribution of caveolin-3 in the human retina was
similar to caveolin-2: IRs were present from the ONL to the
ILM. At the most peripheral regions, IR density was promi-
nent. During retinal development, central portions of the retina
develop first, and peripheral areas develop later [14-16]. Sup-
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TABLE 3. SUMMARY OF LABELING DENSITY OF CAVEOLIN-3 IN
DIFFERENT LOCATIONS OF THE HUMAN RETINA
Region   M     P    CB
------   ---   --   ---
PE       -     -    ++
OS       -     ++   +++
OLM      -     -
ONL      ++    ++
OPL      ++    ++
INL      +     ++
IPL      +++   ++
GC       ++    ++
ONF      +++   ++
ILM      +++   ++
Caveolin-3 was observed in the outer nuclear layer (ONL) and the
inner limiting membrane (ILM), including the intervening layers,
showing very low, low and moderate densities (M). At the peripheral
part (P) IRs immunoreactivities (IRs) also occurred in the layer of
the outer segments (P). At the ciliary body (CB) caveolin-3 signals
could be seen in both layers with low and moderate densities. - indi-
cates none; + indicates very low; ++ indicates low; +++ indicates
moderate; ++++ indicates high; +++++ indicates very high. Follow-
ing abbreviations are used: pigment epithelium (PE), outer segments
(OS), outer limiting membrane (OLM), outer plexiform layer (OPL),
inner nuclear layer (IPL), inner plexiform layer (INL), ganglion cells
(GC), optic nerve fibers (ONF).
Figure 3. Immunocytochemical analysis of
caveolin-3 in the human retina.  Samples were
taken as described in Figure 1. Alexa Fluor 488
was used to detect caveolin-3 (green). The cytosk-
eleton and the nuclei were treated with Alexa fluor
594 labeled phalloidin (red) and DAPI (blue), re-
spectively. Presented images are merged. Caveolin-
3 was observed in the outer nuclear layer (ONL)
and the inner limiting membrane (ILM), includ-
ing the intervening layers. A, D, and F: show very
low, low, and moderate densities (M). B, E, G: At
the peripheral part (P) IRs also occurred in the layer
of the outer segments (low). C: At the ciliary body
(CB), caveolin-3 signals could be seen in both lay-
ers (low, moderate). Note, that pigment granules
show autofluorescence. Scale bar represents 10 µm.
Following abbreviations are used in this figure:
outer segments (OS), outer limiting membrane
(OLM), outer plexiform layer (OPL), inner nuclear layer (IPL), inner plexiform layer (INL), ganglion cells (GC), optic nerve fibers (ONF).
885porting previous observations about chicken development [13],
caveolin-3 gives the highest density in this special, two lay-
ered peripheral part, which represents an early developmental
stage of the retina.
Conclusion:  The quantity and distribution of the caveolin
isoforms in the human retina are different from that found in
other animals. Caveolins are present in more regions and in
more layers in the human retina than in other species. Although
caveolin is a conservative protein, the amount and distribu-
tion of caveolin in different tissues may exhibit considerable
changes across species. Further data are needed to map the
species-specific distribution of the detectable isoforms.
Further investigations are needed to explain the role played
by caveolins in the intact human retina and in that of other
species. Our observations demonstrate that in contrast to pre-
vious beliefs, there is no shortage of caveolins in the retina. It
is hoped this study will facilitate additional research into the
tissue specificity of caveolins. Since the retina contains a num-
ber of different neuronal and glial cell types, the caveolin ex-
pression of these cells can no longer be a matter of dispute.
ACKNOWLEDGEMENTS
 The authors would like to thank Attila Magyar and Botond
Ígyártó for providing non-specific antibodies used as controls
in our experiments.
REFERENCES
 1. Bridges CC, El-Sherbeny A, Roon P, Ola MS, Kekuda R,
Ganapathy V, Camero RS, Cameron PL, Smith SB. A compari-
son of caveolae and caveolin-1 to folate receptor alpha in retina
and retinal pigment epithelium. Histochem J 2001; 33:149-58.
2. Carter-Dawson LD, LaVail MM. Rods and cones in the mouse
retina. II. Autoradiographic analysis of cell generation using tri-
tiated thymidine. J Comp Neurol 1979; 188:263-72.
3. Ueda H. Caveolin-1 localization in Muller cells of the retina. Acta
Histochem Cytochem 2002; 35:423-8.
4. Kachi S, Yamazaki A, Usukura J. Localization of caveolin-1 in
photoreceptor synaptic ribbons. Invest Ophthalmol Vis Sci 2001;
42:850-2.
5. Kim H, Lee T, Lee J, Ahn M, Moon C, Wie MB, Shin T. Immuno-
histochemical study of caveolin-1 and -2 in the rat retina. J Vet
Sci 2006; 7:101-4.
6. Kiss AL, Turi A, Muller N, Kantor O, Botos E. Caveolae and
caveolin isoforms in rat peritoneal macrophages. Micron 2002;
33:75-93.
7. Nishiyama K, Trapp BD, Ikezu T, Ransohoff RM, Tomita T,
Iwatsubo T, Kanazawa I, Hsiao KK, Lisanti MP, Okamoto T.
Caveolin-3 upregulation activates beta-secretase-mediated cleav-
age of the amyloid precursor protein in Alzheimer’s disease. J
Neurosci 1999; 19:6538-48.
8. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family
of scaffolding proteins for organizing “preassembled signaling
complexes” at the plasma membrane. J Biol Chem 1998;
273:5419-22.
9. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet
J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. Cell-type
and tissue-specific expression of caveolin-2. Caveolins 1 and 2
co-localize and form a stable hetero-oligomeric complex in vivo.
J Biol Chem 1997; 272:29337-46.
10. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti
MP. Caveolin isoforms differ in their N-terminal protein se-
quence and subcellular distribution. Identification and epitope
mapping of an isoform-specific monoclonal antibody probe. J
Biol Chem 1995; 270:16395-401.
11. Shin DH, Kim JS, Kwon BS, Lee KS, Kim JW, Kim MH, Cho
SS, Lee WJ. Caveolin-3 expression during early chicken devel-
opment. Brain Res Dev Brain Res 2003; 141:83-9.
12. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti
MP. Co-purification and direct interaction of Ras with caveolin,
an integral membrane protein of caveolae microdomains. De-
tergent-free purification of caveolae microdomains. J Biol Chem
1996; 271:9690-7.
13. Tang ZL, Scherer PE, Lisanti MP. The primary sequence of mu-
rine caveolin reveals a conserved consensus site for phosphory-
lation by protein kinase C. Gene 1994; 147:299-300.
14. Way M, Parton RG. M-caveolin, a muscle-specific caveolin-re-
lated protein. FEBS Lett 1995; 376:108-12. Corrected and re-
published in: FEBS Lett 1996; 378(1):108-12.
15. Weidman TA, Kuwabara T. Development of the rat retina. Invest
Ophthalmol 1969; 8:60-9.
16. Young RW. Cell differentiation in the retina of the mouse. Anat
Rec 1985; 212:199-205.
©2007 Molecular Vision Molecular Vision 2007; 13:881-6 <http://www.molvis.org/molvis/v13/a96/>
886
The print version of this article was created on 15 Jun 2007. This reflects all typographical corrections and errata to the article through that
date. Details of any changes may be found in the online version of the article. α